Resources for Patients and Caregivers
Symptoms that occur when someone stops using alcohol after a period of heavy drinking. Symptoms of alcohol withdrawal can vary widely in severity. In severe cases, the condition can be life-threatening.
Symptoms may occur from two hours to four days after stopping alcohol. They may include headaches, nausea, tremors, anxiety, hallucinations, and seizures.
In many cases, alcohol withdrawal requires medical treatment and hospital admissions. Medications may be used to treat physical symptoms while counseling and support groups help with controlling drinking behavior.
Wiki Number: 05-Alcohol Withdrawal
Diagnosis: Alcohol Withdrawal
Brain Area: May alter genetics and GABA receptors In the brain. May have prolonged withdrawal due to dopamine underactivity.
Symptoms: anxiety, shakiness, sweating, vomiting, hallucinations and delerium
Progression: Start about six hours after the last drink, worst at 24-72 hours, improve by seven days.
Medications: Benzodiazepines but these also have negative side effects.
Alcohol Withdrawal Symptoms Overview
Amazon or Library Book: Alcohol Withdrawal Symptoms
Click the book to link or order from Amazon.
Support Group: aa.org (Alcoholics Anonymous)
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in femalesby Megan E Castle on March 4, 2024
Alcohol Use Disorder (AUD) is a leading cause of death and disability worldwide, but current treatments are insufficient in fully addressing the symptoms that often lead to relapses in alcohol consumption. The brain's serotonin system has been implicated in AUD for decades and is a major regulator of stress-related behaviors associated with increased alcohol consumption. This review will discuss the current literature on the association between neurobiological adaptations in serotonin systems...
- Reliability and validity of the Estonian version of the Clinical Institute of Withdrawal Assessment for Alcohol scaleby Teelia Rolko on March 4, 2024
CONCLUSION: Our study provides confirmation that the CIWA-Ar tool is well applicable in the Estonian language and culture setting.
- Erratum: Management of alcohol withdrawal syndrome in patients with alcohol-associated liver diseaseon March 4, 2024
- A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocolby Anjali K Bhardwaj on March 3, 2024
BACKGROUND: Cannabis use disorder (CUD) is increasingly common and contributes to a range of health and social problems. Cannabidiol (CBD) is a non-intoxicating cannabinoid recognised for its anticonvulsant, anxiolytic and antipsychotic effects with no habit-forming qualities. Results from a Phase IIa randomised clinical trial suggest that treatment with CBD for four weeks reduced non-prescribed cannabis use in people with CUD. This study examines the efficacy, safety and quality of life of...